Regeneron
Regeneron Launches $500M Venture Fund Led by Former Executives
Regeneron/ venture fund/ $500 million/ biotech/ former executives/ innovation/ investment/ 2024.
Regeneron Unveils $500M Biotech-Focused Venture Capital Fund
Regeneron, Venture Capital Fund, Biotech, $500 million
Regeneron Antitrust Suit Against Novartis Gains Momentum with Appellate Ruling
Regeneron, Novartis, Antitrust lawsuit, Appeal court backing, Eye treatments (Eylea & Lucentis), Patent dispute
Sanofi, Regeneron Win Dupixent Label Expansion to Treat Eosinophilic Esophagitis
Eosinophilic esophagitis, Dupixent, Child, Treatment intent, sanofi, Regeneron